title: Rapid Infusion of Rituximab in a Heterogenous Pediatric Population: Safety and Feasibility.
authors.affiliation: Departments of *Pharmacy ‡Oncology-Hematology, CHU Ste Justine §Pediatrics, Microbiology, Infectiology and Immunology, University of Montreal Montreal, QC, Canada †Department of Pharmacy, CHU d'Angers University of Angers, Angers, France.
authors.forename: Clément
authors.initials: C
authors.lastname: Legeay
authors.forename: Laurence
authors.initials: L
authors.lastname: Spiesser-Robelet
authors.forename: Henrique
authors.initials: H
authors.lastname: Bittencourt
authors.forename: Elie
authors.initials: E
authors.lastname: Haddad
authors.forename: Roxane
authors.initials: R
authors.lastname: Therrien
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D008297:Male; D000069283:Rituximab / Q000008:administration & dosage*; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D007155:Immunologic Factors; D000069283:Rituximab